Alkahestincis A Clinical Stage Biotechnology Company Based In San Carloscaliforniafounded In 2014It Focuses On Discovering And Developing Therapies For Age Related Diseasesparticularly Neurodegenerative Conditions Like Alzheimer S Disease And Dementiaas A Subsidiary Of Grifolsa Global Healthcare Companyalkahest Benefits From A Strong Partnership That Enhances Its Research Capabilities The Company Is Engaged In Innovative Research Centered On The Plasma Proteomestudying Factors In Blood Plasma That May Reverse Cognitive Decline Associated With Agingalkahest Is Developing A Range Of Plasma Based Therapiesincluding Akst1210Which Is Currently In A Pilot Phase 2 Studywith A Dedicated Team Of Approximately 82 Employeesalkahest Aims To Slow The Biological Processes Of Aging Through Its Therapeutic Candidates And Collaborations
